Related Experiment Videos
The genus Campylobacter: a decade of progress
1Department of Microbiology, Faculty of Medicine, University of Toronto, Ontario, Canada.
Abstract:
In 1977, microbiologists and clinicians were awakened to the importance of the genus Campylobacter when it was learned that one species, Campylobacter jejuni, was a major cause of human enteritis. In the following decade substantial advances were made in diagnosis, isolation technology, identification, classification, serotyping, and epidemiology. The genus has undergone rapid expansion as advantage was taken of the deoxyribonucleic acid-deoxyribonucleic acid hybridization technique in defining new species. The 14 species now included in the genus, however, constitute a widely diverse group, and one species, C. pylori, which is associated with human gastroduodenitis, is under consideration for reassignment to another genus. The nomenclature of the subspecies of C. fetus has been resolved and the role of C. fetus subsp. fetus as an agent of human infections has been more clearly defined. The thermophilic campylobacteria that are etiological agents of human enteritis now include three species, C. jejuni, C. coli, and C. laridis. Recently defined species that have also been implicated as enteritis-causing agents include C. hyointestinalis, "C. upsaliensis," "C. cinaedi," and "C. fennelliae." The aerotolerant campylobacteria are now included in the species C. cryaerophila, and the campylobacteria isolated from salt marshes are included in C. nitrofigilis. The taxonomy and nomenclature of C. sputorum have been revised. C. sputorum now consists of three biovars (biotypes). Two of these, biovar sputorum and biovar bubulus, were previously considered to be separate subspecies and the third, biovar fecalis, was previously regarded as a separate species and known as "C. fecalis." The former subspecies C. sputorum subsp. mucosalis has been elevated to the rank of species. C. mucosalis is metabolically closely related to C. consisus. Human pathogens have not been identified among C. sputorum, C. mucosalis, or C. concisus. The goal of this article is to review developments during the last 10 years with emphasis on changes in taxonomy that are important from the perspective of the clinical microbiologist.
Insights
The Campylobacter genus expanded significantly, with new species identified and taxonomic classifications updated over a decade. These changes impact clinical microbiology and our understanding of bacterial infections.
Area of Science:
- Clinical Microbiology
- Bacterial Taxonomy
- Infectious Diseases
Background:
- The genus Campylobacter gained prominence in 1977 due to Campylobacter jejuni causing human enteritis.
- Significant advancements in diagnostic and epidemiological tools followed, enabling a broader understanding of Campylobacter species.
Purpose of the Study:
- To review a decade of developments in the genus Campylobacter, focusing on taxonomic changes.
- To highlight the clinical relevance of these taxonomic shifts for microbiologists.
Main Methods:
- Utilized deoxyribonucleic acid-deoxyribonucleic acid hybridization for species definition and genus expansion.
- Reviewed and revised existing classifications for species and subspecies within Campylobacter.
- Analyzed epidemiological data and clinical associations for newly identified and reclassified species.
Main Results:
- The genus Campylobacter expanded to 14 species, showing significant diversity.
- Key species implicated in human enteritis include Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis, with others like Campylobacter hyointestinalis also implicated.
- Taxonomic revisions resolved nomenclature issues for Campylobacter fetus subspecies and reclassified Campylobacter sputorum into three biovars, including the elevation of Campylobacter sputorum subsp. mucosalis to species rank.
Conclusions:
- The rapid taxonomic evolution of the Campylobacter genus necessitates updated understanding for clinical practice.
- Several species, including Campylobacter pylori (under consideration for reassignment), Campylobacter sputorum, Campylobacter mucosalis, and Campylobacter concisus, have been clarified regarding their clinical significance or lack thereof.